Atrial Fibrillation,Hypertension Clinical Trials Database - Free Access to 11 Studies
Access comprehensive clinical trial information for Atrial Fibrillation,Hypertension through Pure Global AI's free database. This collection includes 11 clinical trials across multiple phases including N/A, Phase 3, Phase 4. Currently, 2 trials are actively recruiting participants.
Research for Atrial Fibrillation,Hypertension is being conducted in United Kingdom, China, Germany,United States of America and 5+ other countries. Leading sponsors include Meshalkin Research Institute of Pathology of Circulation and Beijing Anzhen Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Left Atrial Strain Values as an Early Predictor of Atrial Fibrillation
Cardiovascular Risk Reduction in Atrial Fibrillation Trial
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older
Effect of Vit D on New-onset AF in Hypertension
AF Ablation With or Without ROX Coupler Study
Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation
Renal Denervation Therapy in Hypertensive Patients Undergoing A-Fib Ablation
Ganglionated Plexi Ablation vs Renal Denervation in Patients Undergoing Pulmonary Vein Isolation
Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation
Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers
Pure Global AI provides free access to 11 clinical trials studying Atrial Fibrillation,Hypertension, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 8+ countries.
Top research sponsors include Meshalkin Research Institute of Pathology of Circulation, Beijing Anzhen Hospital, Connolly, Stuart, M.D., among others.